Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Jeevan Scientific Technology Ltd is an independent clinical contract research organization (CRO) focusing on delivering technology-driven clinical research solutions globally.
Initially, the company diversified into product development for various industries like edible oil and hospital management, highlighting a broad operational scope.
In recent years, Jeevan Scientific has significantly expanded its clinical research capabilities, offering comprehensive services from bioavailability studies to full Phase I-IV trials.
The establishment of a bioanalytical lab and clinical pharmacology unit underscores the company's commitment to advancing its research infrastructure.
The divestment of subsidiaries Enhops Solutions Private Limited and Enhops Inc marks a strategic realignment, focusing on core operations in clinical research.
Healthcare Services
Healthcare Research, Analytics & Technology
158 Cr
Low Risk
-51.4
56.4
—
2.5
76.99
32.85
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Jeevan Scientific Technology Ltd (JSTL) is currently trading at 82.08 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Jeevan Scientific Technology Ltd is an independent clinical contract research organization (CRO) focusing on delivering technology-driven clinical research solutions globally. Initially, the company diversified into product development for various industries like edible oil and hospital management, highlighting a broad operational scope. In recent years, Jeevan Scientific has significantly expanded its clinical research capabilities, offering comprehensive services from bioavailability studies to full Phase I-IV trials. The establishment of a bioanalytical lab and clinical pharmacology unit underscores the company's commitment to advancing its research infrastructure. The divestment of subsidiaries Enhops Solutions Private Limited and Enhops Inc marks a strategic realignment, focusing on core operations in clinical research.
Over the past 52 weeks, Jeevan Scientific Technology Ltd has traded between a low of ₹32.85 and a high of ₹76.99. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Jeevan Scientific Technology Ltd has a market capitalization of approximately 157.70. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Jeevan Scientific Technology Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -51.37 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 157.70 Cr, Jeevan Scientific Technology Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Jeevan Scientific Technology Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Jeevan Scientific Technology Ltd is -51.37. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
2
Neutral
5
Bullish
7
Bearish
2
Neutral
5
Bullish
39
Bearish
0
Neutral
0
Bullish
32
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
64.02 | 158 Cr | -51.37 | 2.48 | 0.00 | -9.29 | -5.26 | -2.47 | ||
57.69 | 144 Cr | -12.50 | 0.32 | 0.00 | -2.81 | 0.93 | -2.96 | ||
17.03 | 82 Cr | 328.72 | 1.51 | 0.00 | 1.03 | 3.26 | 0.36 | ||
50.29 | 59 Cr | -27.02 | 3.24 | 0.00 | -30.18 | -32.45 | -30.18 | ||
16.98 | 22 Cr | 12.47 | 1.44 | 0.00 | 0.00 | 0.00 | 2.57 | ||
40.50 | 14 Cr | -9.43 | 1.66 | 0.00 | -17.77 | 0.86 | -3.87 | ||
15.15 | 12 Cr | -2.55 | 0.80 | 0.00 | -23.51 | -15.08 | -7.97 | ||
| Median: 7 Co. | — | 40.50 | 59 Cr | -9.43 | 1.51 | 0.00 | -9.29 | 0.00 | -2.96 |
Regulatory Disclosure
Jeevan Scientific Technology Ltd filed its annual SEBI disclosure for FY2025-26 with BSE, confirming it does not qualify as a 'Large Corporate' and reporting nil/not‑applicable mandatory debt‑borrowing metrics.
Regulatory disclosure
Jeevan Scientific Technology Ltd filed SEBI Annexure A stating outstanding borrowings of Rs.11.58 crore (as on 31.03.2026), no applicable credit rating, and confirms it does NOT qualify as a 'Large Corporate' under the SEBI framework.
Compliance Disclosure
Jeevan Scientific Technology Ltd files SEBI annual disclosure for FY2025-26 stating it does not qualify as a Large Corporate, reports nil incremental/debt borrowings for the block and no penalty payable.
